Marc Wenger
Papers
2
Total Citations
77
H-Index
2
About
Marc Wenger is a bioprocess researcher whose work sits at the intersection of vaccine manufacturing, automation, and high-throughput process development. His research focuses on developing innovative strategies to accelerate and refine the production of biologics, particularly recombinant and live virus vaccines. Wenger's most influential contribution, published in 2007 and accumulating 66 citations, introduced an automated microscale chromatographic purification platform for virus-like particles—a significant advance that enabled rapid, resource-efficient process development by integrating expression optimization with product quality assessment at the microscale level. This work addressed a critical bottleneck in recombinant vaccine development, offering the field a more systematic and scalable approach to downstream processing. Building on this foundation, his 2015 study extended these principles to live virus vaccines produced under biosafety level 2 conditions, deploying an integrated robotic system capable of navigating the complex, multifactorial nature of viral culture processes. Together, these contributions reflect Wenger's sustained commitment to bringing engineering rigor and automation to biological manufacturing, helping to compress development timelines and improve the consistency of vaccine production—work of clear relevance to global public health efforts.
Research Focus
Key Achievements
Top Papers
- 1
- 2